Brahemi et al., 2010 - Google Patents
Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancerBrahemi et al., 2010
View HTML- Document ID
- 6150682789691374564
- Author
- Brahemi G
- Kona F
- Fiasella A
- Buac D
- Soukupová J
- Brancale A
- Burger A
- Westwell A
- Publication year
- Publication venue
- Journal of medicinal chemistry
External Links
Snippet
The zinc-ejecting aldehyde dehydrogenase (ALDH) inhibitory drug disulfiram (DSF) was found to be a breast cancer-associated protein 2 (BCA2) inhibitor with potent antitumor activity. We herein describe our work in the synthesis and evaluation of new series of zinc …
- 230000002401 inhibitory effect 0 title abstract description 115
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Brahemi et al. | Exploring the structural requirements for inhibition of the ubiquitin E3 ligase breast cancer associated protein 2 (BCA2) as a treatment for breast cancer | |
| Lin et al. | ent-Kaurane diterpenoids from Chinese liverworts and their antitumor activities through Michael addition as detected in situ by a fluorescence probe | |
| Jin et al. | Design, synthesis, and anticancer evaluation of novel quinoline derivatives of ursolic acid with hydrazide, oxadiazole, and thiadiazole moieties as potent MEK inhibitors | |
| CN113164495B (en) | Covalent targeting of E3 ligases | |
| Liang et al. | Structure, functions and selective inhibitors of HDAC6 | |
| Marson | Histone deacetylase inhibitors: design, structure-activity relationships and therapeutic implications for cancer | |
| US20160051619A1 (en) | Treatment of protein degradation disorders | |
| Wang et al. | Design and SAR of withangulatin A analogues that act as covalent TrxR inhibitors through the Michael addition reaction showing potential in cancer treatment | |
| WO2011097218A1 (en) | Anti-cancer therapeutic agents | |
| US20100113600A1 (en) | Anti-cancer agents and androgen inhibition activity compound | |
| Ding et al. | Regio-and stereospecific synthesis of oridonin D-ring aziridinated analogues for the treatment of triple-negative breast cancer via mediated irreversible covalent warheads | |
| Ling et al. | Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity | |
| US9757350B2 (en) | Small molecule inhibitors of replication protein A that also act synergistically with cisplatin | |
| Xu et al. | In vitro and in vivo antitumor effects of plant-derived miliusanes and their induction of cellular senescence | |
| Schobert et al. | Pt (II) complexes of a combretastatin A-4 analogous chalcone: effects of conjugation on cytotoxicity, tumor specificity, and long-term tumor growth suppression | |
| Poornima et al. | Novel Gomisin B analogues as potential cytotoxic agents: Design, synthesis, biological evaluation and docking studies | |
| Lin et al. | MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: in vitro and in vivo study | |
| Heilos et al. | Altered membrane rigidity via enhanced endogenous cholesterol synthesis drives cancer cell resistance to destruxins | |
| Duan et al. | Oridonin induces oxidative stress-mediated cancer cells apoptosis via targeting thioredoxin reductase | |
| Goldsborough et al. | Collateral sensitivity of multidrug-resistant cells to the orphan drug tiopronin | |
| Baby et al. | Lysine-specific demethylase 1 (LSD1) inhibitors: peptides as an emerging class of therapeutics | |
| Chidambaram et al. | Design, synthesis, and characterization of α, β‐unsaturated carboxylic acid, and its urea based derivatives that explores novel epigenetic modulators in human non‐small cell lung cancer A549 cell line | |
| Stein et al. | B-nor-methylene colchicinoid PT-100 selectively induces apoptosis in multidrug-resistant human cancer cells via an intrinsic pathway in a caspase-independent manner | |
| US20170029388A1 (en) | Treatment of Neurodegenerative Diseases with Asparagine Endopeptidase (AEP) Inhibitors and Compositions Related Thereto | |
| US7749988B2 (en) | Triterpenoid derivatives |